Send feedback

PRX p.Pro280Leu

c.839C>T · rs557355077 · VCV543387

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 5 submitters
AlphaMissense
likely benign
0.0711 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0173%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
Charcot-Marie-Tooth disease

Computational evidence

Protein change
AlphaMissense0.0711likely benign
REVEL0.017moderately benign-leaning
SaProtLLR -4.61tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 1.7GERP -1.5, phastCons 0.01
Regional constrainto/e 1.00unconstrained · MANE · 11 kb · p 0.97 · regional, not allelic
Overall
CADD3.139PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0173% European (non-Finnish) · 199/1,148,778 alleles
Filtering AF 0.0153% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0146%
Overall 0.0144% 223/1,548,932 alleles · ultra-rare exomes 215/1,396,854 · genomes 8/152,078 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0241% 4,156
European (non-Finnish)grpmax 0.0173% 5,773
Remaining individualsnot grpmax-eligible 0.00665% 15,038
African / African-American 0.00546% 18,319
East Asian 0.00243% 41,114
South Asian 0.00235% 42,512

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PRX
Protein
p.Pro280Leu
Coding
c.839C>T
MANE Select
NM_181882
dbSNP
rs557355077
Type
single nucleotide variant
Location
chr19:40397513 (GRCh38)
Gene constraint
LOEUF 1.321 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 35.74 · 1 PDB
Full PRX gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/prx-p-pro280leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown